NanoViricides Reports That Its CEO Dr. Seymour Will Be Interviewed...

... and future Ebola epidemics. The highly customizable nanomedicine cGMP capable pilot scale manufacturing facility in Shelton, CT, will be able to supply all of the nanoviricides drug candidates in quantities needed for human clinical trials. The ...



via Shelton Newswire http://ift.tt/XyDIrR